Literature DB >> 10619562

TGFalpha and the blood-brain barrier: accumulation in cerebral vasculature.

W Pan1, K Vallance, A J Kastin.   

Abstract

Transforming growth factor alpha (TGFalpha) is a cytokine that belongs to the epidermal growth factor (EGF) family of growth factors. EGF has a fast and saturable entry from blood to brain that is inhibitable by TGFalpha (18). In this report, we studied the passage of TGFalpha from blood to brain after an i.v. bolus injection. Using radioactively labeled peptide, we found that TGFalpha had an apparent rate of entry of 0.7 microl/g/min. However, most of the TGFalpha was trapped in the capillary endothelial cells of the cerebral vasculature rather than entering the brain parenchyma. No saturation was detected. TGFalpha was relatively stable in blood for 20 min after i.v. injection, but dissociation of the isotope 125I was more evident in brain. The accumulation of TGFalpha in the cerebral vasculature was similar to that of amyloid-beta protein1-40. Therefore, we conclude that TGFalpha from the periphery interacts with the blood-brain barrier without substantial uptake into brain parenchyma. This raises the possibility that TGFalpha might be involved in intracranial vascular disorders such as angiopathy.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10619562     DOI: 10.1006/exnr.1999.7215

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  8 in total

Review 1.  Cytokine signaling modulates blood-brain barrier function.

Authors:  Weihong Pan; Kirsten P Stone; Hung Hsuchou; Vamshi K Manda; Yan Zhang; Abba J Kastin
Journal:  Curr Pharm Des       Date:  2011-11       Impact factor: 3.116

Review 2.  Concepts for biologically active peptides.

Authors:  Abba J Kastin; Weihong Pan
Journal:  Curr Pharm Des       Date:  2010-10       Impact factor: 3.116

3.  The fasting polypeptide FGF21 can enter brain from blood.

Authors:  Hung Hsuchou; Weihong Pan; Abba J Kastin
Journal:  Peptides       Date:  2007-10-18       Impact factor: 3.750

Review 4.  Delivery of neurotrophic factors to the central nervous system: pharmacokinetic considerations.

Authors:  R G Thorne; W H Frey
Journal:  Clin Pharmacokinet       Date:  2001       Impact factor: 6.447

5.  Behavioral effects of systemic transforming growth factor-alpha in Syrian hamsters.

Authors:  Jenifer Gilbert; Fred C Davis
Journal:  Behav Brain Res       Date:  2008-12-06       Impact factor: 3.332

Review 6.  The central role of hypothalamic inflammation in the acute illness response and cachexia.

Authors:  Kevin G Burfeind; Katherine A Michaelis; Daniel L Marks
Journal:  Semin Cell Dev Biol       Date:  2015-11-03       Impact factor: 7.727

7.  Targeting cartilage EGFR pathway for osteoarthritis treatment.

Authors:  Yulong Wei; Lijun Luo; Tao Gui; Feifan Yu; Lesan Yan; Lutian Yao; Leilei Zhong; Wei Yu; Biao Han; Jay M Patel; Jessica F Liu; Frank Beier; Lawrence Scott Levin; Charles Nelson; Zengwu Shao; Lin Han; Robert L Mauck; Andrew Tsourkas; Jaimo Ahn; Zhiliang Cheng; Ling Qin
Journal:  Sci Transl Med       Date:  2021-01-13       Impact factor: 17.956

8.  A unique carrier for delivery of therapeutic compounds beyond the blood-brain barrier.

Authors:  Delara Karkan; Cheryl Pfeifer; Timothy Z Vitalis; Gavin Arthur; Maki Ujiie; Qingqi Chen; Sam Tsai; Gerrasimo Koliatis; Reinhard Gabathuler; Wilfred A Jefferies
Journal:  PLoS One       Date:  2008-06-25       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.